Phosphorus Cybersecurity™ Appoints John Vecchi as Chief Marketing Officer May 24, 2022 7:00 am|Vecchi brings more than 25 years of enterprise security experience to accelerate IoT market demand and expansion
Chroma Medicine Strengthens Leadership with Addition of George Golumbeski to Board of Directors and John Maraganore as Strategic Advisor May 24, 2022 7:00 am|George Golumbeski, Ph.D., former EVP of Business Development at Celgene, brings 25+ years of biotech industry experience to…
CNS Pharmaceuticals Announces Presentation at the H.C. Wainwright Global Investment Conference May 24, 2022 7:00 am|HOUSTON, May 24, 2022 /PRNewswire/ — CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in…
HOUSTON AMERICAN ENERGY ANNOUNCES SPUDDING OF FIRST WELL ON CPO-11 VENUS EXPLORATION AREA IN COLOMBIA May 24, 2022 7:00 am|HOUSTON, May 24, 2022 /PRNewswire/ — Houston American Energy Corp. (NYSE MKT: HUSA) today announced that final approvals…
CASI PHARMACEUTICALS ENTERES INTO SUBLICENSE AGREEMENT WITH TIANSHI PHARMACEUTICALS FOR ANTI-CD38 MONOCLONAL ANTIBODY (MAB) CID-103 IN AUTOIMMUNE FIELD May 24, 2022 7:00 am|~ CASI to receive upfront payment of $10 million in two instalments ~
PreludeDx™ to Present DCIS Study Results Assessing Benefit of Adjuvant Endocrine Therapy Using DCISionRT® During Oral Presentation at ASCO 2022 Annual Meeting May 24, 2022 7:00 am|LAGUNA HILLS, Calif., May 24, 2022 /PRNewswire/ — Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision…
Hamilton Lane Joins Latest Round of Funding for Private Market Exchange ADDX May 24, 2022 7:00 am|Investment underscores the firm’s commitment to broadening access to the private markets through innovative technology solutions
NightDragon, Coalfire Partner to Accelerate Portfolio Compliance and Cybersecurity Readiness May 24, 2022 7:00 am|NightDragon companies will benefit from Coalfire expertise in FedRAMP, Cloud Managed Services, and Penetration Testing.
CJ BIO and NatureWorks Working Towards a Master Collaboration Agreement to Commercialize Novel Biopolymer Solutions May 24, 2022 7:00 am|Companies announce signed letter of intent to collaborate on creating advanced products based on industry-leading Ingeo™ PLA and…
TransAlta Announces TSX Acceptance of Normal Course Issuer Bid May 24, 2022 7:00 am|CALGARY, AB, May 24, 2022 /PRNewswire/ – TransAlta Corporation (“TransAlta” or the “Company”) (TSX: TA) (NYSE: TAC) announced…